Vertex and CRISPR Therapeutics gain FDA approval for CASGEVY - World's first sickle cell treatment using CRISPR gene editing technology : vimarsana.com

Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patient’s own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.

Related Keywords

Ohio , United States , California , University Of Chicago , Illinois , Saudi Arabia , Washington , Texas , Ohio State University , Switzerland , Australia , Dallas , Philadelphia , Pennsylvania , Massachusetts , United Kingdom , Boston , Columbus , San Francisco , Chicago , Bahrain , London , City Of , San Antonio , Great Britain , America , Kingdom Of Saudi Arabia , Saudi , Los Angeles , Rachel Eides , Susan Kim , Reshma Kewalramani , Stephan Grupp , Samarth Kulkarni , Manisha Pai , Heather Nichols , Regulatory Agency , Youtube , Facebook , National Health Regulatory Authority , Exchange Commission , European Medicines Agency , City Of Hope Children Cancer Center , Instagram , Viacyte Inc , Companies To Work , Drug Agency , Vertex Pharmaceuticals Incorporated Nasdaq , Children National Hospital , Linkedin , Boston Medical Center , Therapeutics Inc , University Of Chicago Comer Children Hospital , Ohio State University Comprehensive Cancer Center , Vertex Pharmaceuticals , Solove Research Institute In Columbus , Drug Administration , Kelly Center , Vertex Pharmaceuticals Incorporated , Steering Committee , Sickle Cell Disease , Pharmaceuticals Incorporated , Chief Executive Officer , Section Chief , Cellular Therapy , Transplant Section , Steering Committee Chair , Medical Center , National Hospital , Hope Children , Cancer Center , City Children , Tristar Centennial , James Cancer Hospital , Solove Research Institute , Comer Children , Saudi Food , Prescription Drug User Fee Act , Financial Reporting , Vertex Connects , Care Managers , Prescribing Information , Patient Information , North America , Top Employers , Private Securities Litigation Reform Act , Forward Looking Statement , Vertex , Rispr Therapeutics , Rispr , Rispr Cas9 , As9 , Casgevy , Ickle Cell , Ickle Cell Disease , Ene Editing , Enes , Herapy , Hemotherapy , One Marrow , Emoglobin , Notebook , Aptop , Eview , Eviews , Ests , Est , Eports , Etbook , Enchmarks , Raphics Card , Rocessor ,